These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8068304)

  • 1. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
    Nachnani S; Scuteri A; Newman MG; Avanessian AB; Lomeli SL
    J Periodontol; 1992 Jul; 63(7):576-83. PubMed ID: 1324301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
    Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
    Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    Clin Ther; 1990; 12 Suppl C():13-24. PubMed ID: 2390771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A collaborative study of French laboratories to assess any evolution of antibiotic resistance within the Bacteroides fragilis group.
    Dubreuil L; Breuil J; Derriennic M; Sedallian A; Dublanchet A; Burnat C; Courtieu A; Romond C
    J Pharm Belg; 1990; 45(5):311-8. PubMed ID: 2086755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tigecycline against Bacteroides species.
    Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
    Aldridge KE; Sanders CV
    J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rosenblatt J; Venezia R; Gorbach SL; Queenan AM; Hecht DW
    Anaerobe; 2011 Aug; 17(4):147-51. PubMed ID: 21664469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group.
    Wexler HM; Finegold SM
    J Chemother; 1991 Feb; 3 Suppl 2():12-9. PubMed ID: 2040893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
    Sood A; Angrup A; Ray P; Bala K
    Anaerobe; 2021 Oct; 71():102443. PubMed ID: 34492368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli.
    Valdivieso-García A; Imgrund R; Deckert A; Varughese BM; Harris K; Bunimov N; Reid-Smith R; McEwen S
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):168-74. PubMed ID: 19748428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
    Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
    Wu PH; Chen CH; Lin HH; Tseng KH; Ko WC; Ho MW; Hsueh PR
    Int J Antimicrob Agents; 2023 Jul; 62(1):106822. PubMed ID: 37088437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.